SCHEMBL30199503

SCHEMBL30199503

CC(C)(C)OC(=O)N1CCc2ccc(OCc3ccccc3Cl)cc2C1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.56
NR1H2 P55055 1/20 0.55
SRD5A1 P18405 1/20 0.46
MAPK1 P28482 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
NR4A2 P43354 2/20 0.42
HRH3 Q9Y5N1 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
GHSR Q92847 5/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29097854 1.00 ESR2 (0.56) ESR2NR1H2SRD5A1MAPK1MAOA
SCHEMBL17894538 0.92 ESR2 (0.54) ESR2NR1H2MAPK1HRH3GHSR
SCHEMBL30199330 0.91 ESR2 (0.53) ESR2NR1H2MAPK1HRH3GHSR
SCHEMBL29097900 0.91 ESR2 (0.53) ESR2NR1H2MAPK1HRH3GHSR
SCHEMBL30199418 0.91 ESR2 (0.53) ESR2NR1H2MAPK1HRH3GHSR
SCHEMBL30199064 0.88 NR1H2 (0.55) ESR2NR1H2MAPK1MAOBHRH3
SCHEMBL30199590 0.85 NR1H2 (0.60) ESR2NR1H2MAPK1HRH3GHSR
SCHEMBL29098015 0.85 NR4A2 (0.50) SRD5A1MAOAMAOBNR4A2HRH3
SCHEMBL14541717 0.85 ESR2 (0.64) ESR2NR1H2MAPK1GHSR
SCHEMBL29097892 0.84 ESR2 (0.56) ESR2NR1H2MAPK1MAOBHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594669-B Parallel ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-11-05 CN disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 CN disclosed